Background. In 2009, the Oxford classification was developed as a pathological classification system for immunoglobulin A nephropathy (IgAN) to predict the risk of disease progression. The aim of this retrospective study was to evaluate the clinical and pathologic relevance of the Oxford classification in Korean patients with a pathologic diagnosis of IgAN. Patients and methods. We reviewed the renal pathology archives from January 2000 to December 2006 at Seoul St Mary's Hospital in Korea and identified 273 patients, who were diagnosed as having IgAN. We enrolled 197 patients who were available for further clinicopathologic analysis. All cases of IgAN were categorized according to the WHO classification, the semiquantitative classification and the Oxford classification. These pathologic classifications were compared. The clinical and laboratory findings at the time of biopsy were compared with those at the end of the followup according to the Oxford classification. Results. When three pathologic classifications were compared, M1, S1, E1, T1 or T2 were associated with a higher score in the activity index. S1, T1 or T2 were associated with a higher score in the chronicity index and a higher grade in the WHO classification. The clinical and laboratory findings were compared according to the Oxford classification. At the time of biopsy, the proteinuria in patients with M1 was more than that of M0 (P ¼ 0.035). At the end of follow-up, the number of antihypertensive drugs taken among patients with M1 was greater than that of patients with M0 (P ¼ 0.001). At the time of biopsy, the proteinuria of patients with S1 was greater than that of S0 patients (P ¼ 0.009). At the end of follow-up, the number of patients who received immunosuppressants was increased as the grade of T increased (P ¼ 0.000). At the end point of the followup, the estimated glomerular filtration rate (eGFR) decreased as the grade of T increased (P ¼ 0.008). The time-average proteinuria after adjusting the initial proteinuria increased significantly with increasing degree of T (P ¼ 0.000). Levels of tubular atrophy/interstitial fibrosis were predictive for survival from end-stage renal disease or of having a 50% reduction of eGFR. Conclusion. The pathologic variables of the Oxford classification correlated significantly with other classifications (the WHO classification and the semiquantitative classification). The Oxford classification is a simple method for predicting renal outcome and differentiating between active and chronic lesions. We suggest that the Oxford classification offers an advantage for determining treatment policy for patients with IgAN.
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Background
Immunoglobulin A nephropathy (IgAN) is an immune complex-mediated glomerulonephritis, which was first described by Berger and Hinglais in 1968 in Paris [1, 2] . IgAN is the most common form of primary glomerulonephritis [2, 3] . Although IgAN has been regarded as a benign disease, 20-40% of these patients progressed to end-stage renal disease (ESRD) [2] [3] [4] [5] .
Risk factors linked with progressive IgAN include hypertension, proteinuria >1.0 g/day, male gender, reduced glomerular filtration rate (GFR) and severe pathologic findings on initial renal biopsy [3] [4] [5] [6] . For the latter, various pathologic classification systems have been used and they can be divided into two groups: a grading (lumped) system and a semiquantitative (split) system [5] . The grading system classifies the tissue pathology according to overall severity based on the lesions found in each tissue compartment [6, 7] . The semiquantitative system classifies them according to a semiquantitative severity grading of the various lesions and permits scoring for each of the pathologic variables in the compartments [6] . However, there is continuing debate whether pathologic findings and classifications contribute additional prognostic information beyond that provided by clinical features [8] [9] [10] .
In 2009, the Oxford classification was developed as a pathological classification system to predict the risk of disease progression [9, 10] . The Oxford classification consists of a system based upon four scores (mesangial hypercellularity, segmental glomerulosclerosis, endocapillary hypercellularity, tubular atrophy/interstitial fibrosis). Previously, two studies have shown that each variable is correlated with clinical outcomes [9, 11] . The aim of this retrospective study was to evaluate the clinical and pathologic relevance of the Oxford classification in Korean patients with pathologic diagnosis of IgAN.
Patients and methods
Selection of patients
We reviewed the renal pathology archives from January 2000 to December 2006 at Seoul St Mary's Hospital in Korea and identified 273 patients, who were diagnosed as having IgAN. We enrolled patients, aged >15 years, who were diagnosed with IgAN by initial renal biopsy. Of these, patients with secondary causes of mesangial IgA deposits, such as HenochSchonlein purpura or with comorbid conditions such as diabetes mellitus, liver disease or systemic lupus erythematosis, were excluded from this study. Biopsies containing <5 glomeruli were regarded as inadequate for scoring and were excluded from this study. We enrolled 197 IgAN patients in this study. The hospital's ethics committee approved the study protocol and the study was conducted in accordance with the principles that have their origin in the Declaration of Helsinki.
Clinical and laboratory information
Clinical and laboratory data collected within 1 month of biopsy included the following: gender, age at biopsy (years), reason for renal biopsy, mean arterial pressure (MAP), macroscopic hematuria, treatment modalities, uric acid (mg/dL), serum creatinine (mg/dL), proteinuria (g/day) and estimated glomerular filtration rate (eGFR, mL/min/1.73m
2 ). Data collected concerning follow-up included duration of follow-up, MAP, treatment modalities, serum creatinine, proteinuria, eGFR, rate of renal function decline (mL/min/1.73m 2 /year) and the number of antihypertensive medications. Proteinuria (g/day) was also measured every year, and the mean value was used as an indicator of time-average proteinuria (TAP) [4] . The eGFR was estimated using the abbreviated Modification of Diet in Renal Disease equation [4, 12] . ESRD was defined as an eGFR of <15 mL/min/1.73m 2 or a condition requiring chronic renal replacement therapy [4, 13] . During the follow-up period, patients who received immunosuppressants or antihypertensive drugs were defined as those treated for >6 months.
Pathologic data set
All renal biopsy specimens were routinely divided into three portions. Standard procedures were used to process 10% formalin-fixed tissue for light microscopy. The paraffin-embedded tissue was serially sectioned at 3 lm in thickness and stained with hematoxylin and eosin, periodic acidSchiff, silver methenamine and Masson trichrome. Electron microscopy was performed on a small biopsy piece fixed in glutaraldehyde. Direct immunofluorescence microscopy was used in all cases to detect deposition of IgG, IgA, IgM, C3, C1q, fibrinogen and light chains. At the time of biopsy, all cases of IgAN had been categorized into five classes according to the WHO classification [14] , and an activity index (0-10) and chronicity index (0-12) were also calculated according to a semiquantitative classification [15] . One pathologist reviewed all renal biopsy slides and scored pathologic variables according to the Oxford classification [9] [10] [11] . The four pathologic variables of the Oxford classification were scored as follows:
Mesangial score 0.5 (M0) or > 0.5(M1) Segmental glomerulosclerosis absent (S0) or present (S1) Endocapillary hypercellularity absent (E0) or present (E1) Tubular atrophy atrophy/interstitial fibrosis 25% (T0), 26-50% (T1) or >50% (T2)
We compared the pathologic variables of the Oxford classification with the WHO classification and semiquantitative classification. Also, we compared the clinical and laboratory findings at the time of biopsy with those at the end of follow-up.
Statistical methods
The data were analyzed using SPSS version 15 (SPSS Inc., Chicago, IL). Data are presented as mean AE standard deviation or as counts and percentages. For continuous variables, means were compared using independent t-test or one-way analysis of variance. For categorized variables, Pearson's v 2 -test, Fisher's exact test and a linear by linear association test were used. Univariate followed by multivariate linear regression and logistic regression were used to determine the independent predictors of the pathology and clinical findings at the end point of the follow-up. Survival from a 50% reduction in renal function or ESRD were calculated according to Cox regression. P-values <0.05 were considered to be statistically significant.
Results
Clinical characteristics
The study population was 57.7% male and the mean age at biopsy was 32.4 AE 12 years old. The mean number of glomeruli per biopsy was 15.9 AE 8. Mean follow-up period was 56.8 AE 29.8 months. At the time of renal biopsy and followup, the serum creatinine average was 1.09 AE 0.72 mg/dL and 1.57 AE 2.25 mg/dL, respectively. The eGFR was 87.1 AE 29.2 mL/min/1.73m 2 and 78.9 AE 30.1 mL/min/1.73m 2 . At the time of biopsy, 48 patients (24.4%) were taking antihypertensive drugs. At the end of follow-up, 164 patients (83.2%) were taking antihypertensive drugs, and 75 patients (38.1%) received immunosuppression ( Table 1) .
Comparison of the Oxford and WHO or semiquantitative classifications
The distribution of patients based on the WHO classification was 8 (4.1%) in I, 48 (24.4%) in II, 93 (47.2%) in III, 39 (19.8%) in IV and 9 (4.6%) in V. In the semiquantitative classification, the means of the activity and chronicity index were 2.58 AE 1.23 and 2.98 AE 1.93, respectively. The distribution of pathologic variables by the Oxford classification was as follows: M0/M1, 145/52 (73.6/26.4%); S0/ S1, 86/111 (43.7/56.3%); E1/E2, 175/22 (88.8/11.2%) and T0/T1/T2, 131/51/15 (66.5/25.9/7.6%).
The portions of M1, S1, E1, T1 or T2 were significantly increased as the WHO class score increased ( Figure 1 ). The pathologic variables of the Oxford classification, except the chronicity index with E of the Oxford classification, correlated significantly with the activity and chronicity indices ( Figure 2 ).
To identify the pathologic variables in the Oxford classification affecting different pathology classifications, the pathologic parameters were analyzed by multivariate regression models (Table 2) . M1, S1, E1, T1 or T2 were associated with a higher score in the activity index. S1, T1 or T2 were associated with a higher score in the chronicity index and a higher grade of the WHO classification.
Clinicopathologic correlations according to the Oxford classification
At the time of biopsy, the proteinuria of patients in M1 was greater than that of M0 (1.36 AE 2.47 in M0, 2.33 AE 2.88 in M1; P ¼ 0.035). The patients with M1 received more intensive treatment such as immunosuppression and reninangiotensin system (RAS) blockade. At the time of biopsy and the end of follow-up, creatinine and eGFR were not associated with M (Table 3) .
At the time of biopsy, the proteinuria of patients with S1 was greater than that of S0 (1.48 AE 2.32 in S0, 2.54 AE 3.07 in S1; P ¼ 0.009). The TAP of S1 patients was more than those with S0 (0.77 AE 1.14 in S0, 1.39 AE 1.64 in S1; P ¼ 0.002). The eGFR of S1 patients was lower than those of S0 (85.3 AE 26.1 in S0, 74.3 AE 32.0 in S1; P ¼ 0.013). The patients taking antihypertensive drugs in the S1 group were greater in number than in S0 (79% in S0, 92.6% in S1; P ¼ 0.006). There were more patients who received immunosuppression in group S1 than in group S0 (21.3% in S0, 53.7% in S1; P ¼ 0.000) ( Table  3) . Despite more intensive management, patients in S1 had a lower follow-up eGFR and a higher TAP than those in S0.
At the time of biopsy, there was no significant difference in the clinical findings based on E findings. The distribution of patients taking antihypertensive drugs or immunosuppressants was similar between E0 and E1 (P ¼ 1.000, P ¼ 0.050). At the end of follow-up, there was no significant difference in the clinical findings based on E (Table 4) .
When patients were stratified into two 'grades' of T, by lesions showing greater or <25% tubular atrophy/interstitial fibrosis, there were significant differences in proteinuria at the time of biopsy (1.73 AE 2.91 in T0, 2.73 AE 2.49 in T1 or T2; P ¼ 0.019). The serum creatinine at biopsy was significantly increased as the grade of T rose (0.95 AE 0.40 in T0, 1.18 AE 0.46 in T1, 2.00 AE 2.00 in T2; P ¼ 0.000). The eGFR at biopsy was significantly decreased as degree of T rose (95.4 AE 27.1 in T0, 74.2 AE 21.2 in T1, 59.1 AE 38.2 in T2; P ¼ 0.000). The TAP was significantly increased as the degree of T increased (0.85 AE 1.19 in T0, 1.56 AE 1.61 in T1, 1.99 AE 2.36 in T2; P ¼ 0.001). However, the proteinuria of T1 patients at last visit was greater than that of T0 or T2 (0.52 AE 1.17 in T0, 1.29 AE 1.95 in T1, 0.97 AE 1.21 in T2; P ¼ 0.010). The creatinine increased significantly as the degree of T rose (1.12 AE 1.12 in T0, Table 4 ). Patients with T0 had a higher follow-up eGFR and lower TAP than those with T1 or T2. Multivariate regression analysis revealed the number of patients taking drugs for a RAS blockade and the number of antihypertensive drugs to be associated with M and S. The number of patients who received immunosuppression was associated with S. The eGFR at the end point of the followup was associated with T ( Table 5 ). The TAP after adjusting the initial proteinuria increased significantly with increasing degree of T (standardized b ¼ 0.155, P ¼ 0.000) ( Table 6 ).
The effects of independent variables in the Oxford classification on survival from ESRD or a 50% reduction in eGFR are given in (Table 7) . The lesion showing >25% tubular atrophy/interstitial fibrosis was associated with a significantly increased relative risk of ESRD or a 50% reduction in eGFR in univariate Cox regression (relative risk 4.494, confidence interval (CI) 1.559-12.957, P ¼ 0.005) and multivariate Cox regression (relative risk 3.652, CI 1.142-11.678, P ¼ 0.022).
Discussion
This study demonstrates that the pathologic variables of the Oxford classification of IgAN are significantly correlated with WHO classification and with semiquantitative classification. The presence of four major pathologic variables in the Oxford classification correlated significantly with a higher class in the WHO classification and higher activity and chronicity index in the semiquantitative classification. The clinical and laboratory findings were also compared according to the Oxford classification. Except for endocapillary hypercellularity, the Oxford classification correlated significantly with clinical findings. An especially strong correlation was found between the degree of tubular atrophy/interstitial fibrosis and survival from ESRD or a 50% reduction of eGFR.
Many pathologists have developed a number of classifications of IgAN. A number of reports have emphasized the prognostic value of pathologic classification [4] [5] [6] . However, there is continuing debate as to whether pathologic findings contribute additional prognostic information beyond that provided by clinical features in IgAN [8] [9] [10] . The histological classifications can be grouped into singlegrade classification (lumped) and semiquantitative (split) classification [5, 16] . The former is mainly based on the glomerular changes. The grading systems such as those of Lee and Haas correlate closely with renal outcomes but do not differentiate active lesions from chronic lesions [17] [18] [19] . The semiquantitative classification is mainly based on a scoring system, which counts the changes in the glomerular, tubulointerstitial and vascular structures. The semiquantitative classification has shown variable success at predicting renal outcomes and the severity of individual parameters. However, critical limitations were a lack of reproducibility among pathologists and the complexity of using it routinely [19] .
To overcome these limitations, many pathologists or nephrologists have continued to investigate new pathologic Values with statistical significance (P value < 0.05) are indicated in bold. a Abbreviations: M, mesangial hypercellularity; S, segmental glomerulosclerosis. Table 4 . Clinical findings at the time of the initial biopsy and the end point of the follow-up according to endocapillary hypercellularity and tubular atrophy/interstitial fibrosis a Endocapillary hypercellularity Tubular atrophy/Interstitial fibrosis Values with statistical significance (P value < 0.05) are indicated in bold. a Abbreviations: E, endocapillary hypercellularity; T, tubular atrophy/interstitial fibrosis.
Our study shows that each pathologic variable of the Oxford classification closely correlates with the WHO classification or semiquantitative classification. The presence of each variable was associated with a higher grade in the WHO classification or a higher score in the semiquantitative classification. Multivariate regression models showed that all pathologic variables in the Oxford classification are correlated with a higher score in the activity index. Segmental glomerulosclerosis and tubular atrophy/interstitial fibrosis were only associated with a higher score in the chronicity index and a higher grade in the WHO classification. Patients with pathologic variables in the Oxford classification require treatment because they are associated with an active lesion. S1, T1 or T2 are associated with a chronic lesion and can be used to predict the long-term prognosis. Therefore, this study demonstrates that the Oxford classification differentiates active lesions from chronic lesions, such as semiquantitative classification, and is a simple method for routine use, such as grading classification. The mesangial hypercellularity score in the Oxford classification is defined as the number of mesangial cells per mesangial area. Previous studies already showed that the mesangial hypercellularity is correlated with an active lesion [5] [6] [7] . However, controversies exist as to whether this is an independent prognostic factor. This study shows that proteinuria at the time of initial biopsy correlated with M1. The patients classified as M1 received more treatment, such as RAS blockade. This demonstrates that mesangial hypercellularity is associated with initial proteinuria, and patients with M1 receive more intensive treatment. S1 in the Oxford classification is classified as the presence of segmental glomerulosclerosis; segmental glomerulosclerosis is well documented as a part of a chronic lesion or as a single predictor for IgAN [5] [6] [7] [8] [9] [10] [11] [17] [18] [19] [20] [21] . Our present study shows that proteinuria at the time of biopsy correlated with S1. However, renal function at the time of biopsy did not correlate with S. The patients with S1 received more treatment such as immunosuppression and RAS blockade. This demonstrates that segmental glomerulosclerosis is associated with initial proteinuria, and patients with S1 receive more intensive treatment. Mesangial hypercellularity and segmental glomeruloscelrosis were associated with initial proteinuria. These variables were not associated with the clinical findings at the end point of the follow-up adjusting the initial proteinuria. However, patients with M1 or S1 received more treatment, which may explain the inconsistency. Although the proteinuria of patients with M1 was greater than that of M0, there was no significant difference between the TAP of patients with M1 and those with M0. This suggests that patients with M1 show a good treatment response.
Endocapillary hypercellularity has been discussed as a part of glomerular hypercellularity (including mesangial hypercellularity) rather than as a single prognostic factor and is generally correlated with active lesions [5] [6] [7] [19] [20] [21] . In the Oxford classification, E1 was indicated by the presence of endocapillary hypercellularity and was defined as a single predictor [9] [10] [11] . Two studies have shown that this variable is correlated with clinical findings [9, 11] . Cattran et al. [9] showed E1 correlated with initial presentation but not with follow-up findings (such as rate of renal function decline) [9] . This study did not show a significant association at the time of biopsy and follow-up, but the trend shows an association between E1 and the initial presentation. We think this is due to the small number of patients with E1. To overcome this, studies looking at more patients are required.
Tubular atrophy/interstitial fibrosis has been well documented as a strong prognostic predictor for IgAN. Previous studies have already shown that tubular atrophy/interstitial fibrosis is associated with a chronic lesion [5] [6] [7] . This variable in the Oxford classification is categorized as T1 (0-25%), T2 (26-50%) or T2 (>50%) [5] [6] [7] [8] [9] [10] [11] [16] [17] [18] [19] [20] . The present study shows that serum creatinine and the eGFR at the time of initial biopsy correlated with T. At the end of follow-up, TAP and eGFR correlated with T. The proteinuria at the end point of the follow-up was substantially lower in three groups but eGFR decreased with increasing grade of T. Many studies showed that the severity of proteinuria over the long term is more important than proteinuria at one point [4] [5] [6] . This phenomenon could be due to the increased TAP with increasing degree of T. This demonstrates that tubular atrophy/ interstitial fibrosis is an independent predictor of TAP and decrease in renal function. In addition, this variable was independently associated with a significantly increased relative risk based upon survival from ESRD or a 50% reduction in eGFR, using multivariate cox regression (M, S and E were also included in the multivariate model, but they were not significant).
In conclusion, our results demonstrate that the pathologic variables of the Oxford classification correlate significantly with the WHO classification and with the semiquantitative classification. The Oxford classification is a simple method for predicting renal outcome and differentiating between active and chronic lesions. However, clinical characteristics according to each pathologic variable by Oxford classification were different. We suggest the Oxford classification offers an advantage for determining treatment policy for patients with IgAN. More large scaled and controlled studies in different races are needed to prove the overall superiority of the Oxford classification.
